Sunday 19 October 2025
Home      All news      Contact us      RSS     
Aljazeera - 4 years ago

Covaxin, India’s homegrown COVID jab, ‘highly efficacious’: Study

Data from Phase 3 trials show vaccine offers 78 percent protection against COVID-19, says a study published in Lancet.


Latest News
Hashtags:   

Covaxin

 | 

India

 | 

homegrown

 | 

COVID

 | 

highly

 | 

efficacious

 | 

Study

 |